Sai Life Sciences Share Price

NSE
760.5
+13.60 (1.86%)
SAILIFE • 25 Jun, 2025 | 12:05 PM
BUY
The current prices are delayed, login or Open Demat Account for live prices.
Sai Life Sciences Stock Performance
Today’s Low - High
747.00
777.25
747.00
777.25
52 Week Low - High
636.10
808.80
636.10
808.80

Open

747.00

Prev. Close

746.90

Total Traded Value

31.57 Cr

View details of Market Depth
Sai Life Sciences Fundamental

Market Cap (in crs)

15,591.79

Face Value

1

Turnover (in lacs)

3,157.23

Key Metrics
Qtr Change %
3.1
Dividend yield 1yr %
0

Sai Life Sciences Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Sai Life Sciences Quarterly Revenue

Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
579.51 Cr
439.78 Cr
395.56 Cr
279.72 Cr
439.21 Cr

Sai Life Sciences Yearly Revenue

Mar 2025Mar 2024Mar 2023Mar 2022
1731.35 Cr
1494.27 Cr
1245.1 Cr
897.74 Cr

Sai Life Sciences Quarterly Net Profit/Loss

Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
88.27 Cr
53.85 Cr
41.51 Cr
-13.5 Cr
56.13 Cr

Sai Life Sciences Yearly Net Profit/Loss

Mar 2025Mar 2024Mar 2023Mar 2022
170.13 Cr
82.81 Cr
9.99 Cr
6.23 Cr
Sai Life Sciences Result Highlights
  • Sai Life Sciences Ltd reported a 1.4% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a - of -.

  • Its expenses for the quarter were down by 2.8% QoQ and - - YoY.

  • The net profit increased 4.2% QoQ and - - YoY.

  • The earnings per share (EPS) of Sai Life Sciences Ltd stood at 3.1 during Q4FY25.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Sai Life Sciences shareholding Pattern

Promoter
35.2%
Foreign Institutions
12.4%
Mutual Funds
11.5%
Domestic Institutions
13.2%
Public
39.2%
Promoter
35.2%
Foreign Institutions
11.7%
Mutual Funds
10.2%
Domestic Institutions
12%
Public
41.1%

Sai Life Sciences Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
760.5
Current Price
Bullish Moving Averages
13
Bearish Moving Averages
0
5Day EMA
750.20
10Day EMA
750.00
12Day EMA
749.50
20Day EMA
746.20
26Day EMA
743.60
50Day EMA
735.50
100Day EMA
725.70
EMA
5Day SMA
746.60
10Day SMA
753.70
20Day SMA
745.80
30Day SMA
743.50
50Day SMA
731.10
100Day SMA
716.70
SMA
SMA
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
628774 Rs
1084685 Rs
Week Rs
4821764 Rs
5506552 Rs
Month Rs
1347031 Rs
1698592 Rs
Resistance & Support
747.30
Pivot
Resistance
First Resistance
758.10
Second Resistance
769.30
Third Resistance
780.10
Support
First Support
736.10
Second support
725.30
Third Support
714.10
Relative Strength Index
51.05
Money Flow Index
64.05
MACD
5.84
MACD Signal
6.95
Average True Range
29.83
Average Directional Index
30.54
Rate of Change (21)
1.56
Rate of Change (125)
6.15
Shareholding
Name
Holding Percent
INVESCO INDIA MIDCAP FUND
2.88
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA PHA
2.48
MIRAE ASSET AGGRESSIVE HYBRID FUND
1.19
HSBC AGGRESSIVE HYBRID FUND
1.12
SMALLCAP WORLD FUND, INC
2.62
GOLDMAN SACHS FUNDS - GOLDMAN SACHS INDIA EQUITY P
1.33

Sai Life Sciences Latest News

23 JUN 2025 | Monday

Sai Life Sciences Ltd - 544306 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

23 JUN 2025 | Monday

Sai Life Sciences Ltd - 544306 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

20 JUN 2025 | Friday

Sai Life Sciences Ltd - 544306 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

View More

Sai Life Sciences Company background

Founded in: 1999
Managing director: Krishnamraju Kanumuri
Sai Life Sciences Limited was originally incorporated as Sai Dru Syn Laboratories Limited as a Public Limited Company, dated January 25, 1999, issued by the Registrar of Companies, Andhra Pradesh at Hyderabad. The Company received the Certificate of Commencement of Business from Registrar of Companies, Andhra Pradesh on February 17, 1999. Subsequently, the Company name was changed from Sai Dru Syn Laboratories Limited to Sai Life Sciences Limited dated December 16, 2003.Thereafter, the name of the Company was changed from Sai Life Sciences Limited to Sai Advantium Pharma Limited dated August 30, 2006 issued by the Registrar of Companies, Andhra Pradesh. Subsequently, the Company name was changed from Sai Advantium Pharma Limited to Sai Life Sciences Limited and a fresh Certificate of Incorporation dated May 28, 2012 was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.The Company is an innovatorfocused contract research, development, and manufacturing organization (CRDMO). The Company provide endtoend services across the drug discovery, development and manufacturing value chain, for small molecule NCE to global pharmaceutical innovators companies and biotechnology firms. It possess both (a) discovery / contract research and (b) CMC / CDMO capabilities.Through the Scheme of Amalgamation, Prasad Drugs Limited was merged into the Company in 2004. The Company acquired Merrifield Pharma Private Limited in 2006. Later, the Company opened new areas of biology facility in Watertown (Greater Boston, MA) U.S.A. for innovative and creative smallmolecule drugs in 2019. It launched Sai Nxt, an initiative to transform the organization into a new generation CDMO in 2020. It further added cellular analysis platforms at its discovery biology facility in Cambridge, Massachusetts, USA.In 2021, the Company opened a new discovery biology facility at Unit II Plant in Hyderabad. In 2022, it opened the first set of new disconvery chemistry labs at Unit III Plant, Hyderabad. In 2023, the Company opened high potency API manufacturing block at Unit IV Bidar Facility and has started API developability formulations (DF) capabilities at Unit II Hyderabad in 2024.The Company is proposing to raise money from public through IPO by issue and allotment of 61,573,120 Equity Shares through Offer for Sale and a Fresh Issue aggregating to Rs 800 Crores Equity Shares.

As of 25 Jun, 2025, Sai Life Sciences share price is ₹761.2. The stock opened at ₹747 and had closed at ₹746.9 the previous day. During today’s trading session, Sai Life Sciences share price moved between ₹747.00 and ₹777.25, with an average price for the day of ₹762.13. Over the last 52 weeks, the stock has recorded a low of ₹636.10 and a high of ₹808.80. In terms of performance, Sai Life Sciences share price has declined by 0.2% over the past six months and has declined by 1.37% over the last year.

Read More

Sai Life Sciences FAQs

Sai Life Sciences share price is ₹760.5 in NSE and ₹760.65 in BSE as on 25/6/2025.

Sai Life Sciences share price in the past 1-year return was 0. The Sai Life Sciences share hit a 1-year low of Rs. 636.1 and a 1-year high of Rs. 808.8.

The market cap of Sai Life Sciences is Rs. 15591.79 Cr. as of 25/6/2025.

The PE ratios of Sai Life Sciences is 89.79 as of 25/6/2025.

The PB ratios of Sai Life Sciences is 7.18 as of 25/6/2025

The Mutual Fund Shareholding in Sai Life Sciences was 11.54% at the end of 25/6/2025.

You can easily buy Sai Life Sciences shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Sai Life Sciences stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

Open Demat Account
+91 -